T-cell receptor sequencing reveals novel biomarkers for ovarian cancer

Researchers used deep T-cell receptor (TCR) sequencing to evaluate the clonal composition of tumor-infiltrating lymphocytes, or TILs, and identify novel prognostic biomarkers in ovarian cancer.